Ropivacaine - CAS# 84057-95-4 3173 and the final reduction at

and the final reduction at 24 hr in mean log cfu/ml is 22

YS-49 (10-100 μM

This derivative may be stable for long periods of time except at high pH

HeLa and Jurkat cells

Ropivacaine - CAS# 84057-95-4 3173 and the final reduction atRopivacain is a potent sodium channel blocker and acts as a local anesthetic agent. Ropivacain blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two pore domain potassium channel) TREK 1 with an IC50 of 402. 7 M in COS 7 cell's membrane. Ropivacaine is used for the research of regional anesthesia and neuropathic pain management. Product information CAS Number: 84057 95 4